Skip to content

Identification of a marker in skin called anti-IgE antibody by microscopy in patients with a blistering disease of skin known as bullous pemphigoid

Detection of anti-IgE antibodies against basement membrane zone in bullous pemphigoid: a cross-sectional study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067574
Enrollment
35
Registered
2024-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L120- Bullous pemphigoid

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Kasturba Medical College Manipal
Lead Sponsor
Saurodeep Basu
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with a clinical diagnosis consistent with bullous pemphigoid as per the standard diagnostic criteria. 2. Direct immunofluorescence (DIF) microscopy showing linear deposits of IgG and/or Complement C3 along the basement membrane zone. 3. Indirect immunofluorescence (IIF) of salt-split skin biopsy showing deposition of IgG along the basement membrane zone, if done.

Exclusion criteria

Exclusion criteria: 1. Severe bleeding and coagulation disorders. 2. Failure to obtain written informed consent for skin biopsy. 3. Severely immunosuppressed conditions, including acquired immunodeficiency syndrome (AIDS).

Design outcomes

Primary

MeasureTime frame
Demonstration of anti-IgE antibodies in basement membrane zone by direct immunofluorescence (DIF) microscopyTimepoint: During hospital stay or on OPD basis

Secondary

MeasureTime frame
• Correlation of anti-BMZ IgE antibodies in skin biopsy with patient characteristics (age, gender, clinical manifestations and duration of the disease) • Bullous pemphigoid disease area index (BPDAI) score • Association between anti-BMZ IgE antibodies in skin biopsy with eosinophil and basophil count in the peripheral blood, and serum IgE and IgG (against BP180 and BP230), if doneTimepoint: During hospital stay or on OPD basis

Countries

India

Contacts

Public ContactSaurodeep Basu

Kasturba Medical College Manipal

jenny.rao@manipal.edu9845292640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026